L3VLUP
ProSign in

VRTX in the 13F filings

Vertex Pharmaceuticals Inc · CUSIP 92532F100

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Q3 2026: 5 of 95 managers have filed so far; the filing deadline is 16 November 2026. Its figures cover those filers only, so it is not yet a picture of the tracked managers.

Quarter end
30 Sep 2026
the date the book describes
Filed
9 Nov 2026
latest of these filings; the earliest 9 Nov 2026
Managers listing it
3
at least, of 95 tracked, among listed positions
Comparable managers
5
filed both Q2 2026 and Q3 2026; 2 listed it in both
Shares listed
372,534
combined, among listed positions
Reported value
$195m
combined, at the quarter end

Among the 5 comparable managers: 1 buyer (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +45,820.

Managers listing VRTX in Q3 2026

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2026, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

3 of 3 holders

ActionFiling
Baillie Gifford & Co266,055$139m0.13%Trimmed-6,5069 Nov 2026 (the filing on sec.gov)
Squarepoint Ops LLC73,294$38munder 0.1%Added+61,2639 Nov 2026 (the filing on sec.gov)
Acadian Asset Management LLC33,185$17munder 0.1%Trimmed-8,9379 Nov 2026 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2026 to Q3 2026, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
26 in Q4 2024 to 3 in Q3 2026

Tracked managers listing it, at least.

0102030402014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
VRTX by quarter
QuarterHoldersReported valueBuyersSellers
Q2 201313$5.0bnn.a.n.a.
Q3 201312$4.6bnn.a.n.a.
Q4 20139$4.8bnn.a.n.a.
Q1 201411$4.9bnn.a.n.a.
Q2 201411$7.3bnn.a.n.a.
Q3 201414$9.0bnn.a.n.a.
Q4 201415$9.3bnn.a.n.a.
Q1 201521$9.2bnn.a.n.a.
Q2 201523$9.4bnn.a.n.a.
Q3 201522$8.3bnn.a.n.a.
Q4 201519$10.2bnn.a.n.a.
Q1 201618$6.8bnn.a.n.a.
Q2 201613$7.5bnn.a.n.a.
Q3 201614$7.7bnn.a.n.a.
Q4 201614$6.3bnn.a.n.a.
Q1 201721$9.5bnn.a.n.a.
Q2 201724$11.0bnn.a.n.a.
Q3 201728$12.6bnn.a.n.a.
Q4 201724$12.2bnn.a.n.a.
Q1 201824$13.3bnn.a.n.a.
Q2 201827$14.0bnn.a.n.a.
Q3 201826$15.7bnn.a.n.a.
Q4 201827$14.6bnn.a.n.a.
Q1 201926$17.0bnn.a.n.a.
Q2 201924$17.0bnn.a.n.a.
Q3 201925$16.0bnn.a.n.a.
Q4 201929$20.0bnn.a.n.a.
Q1 202027$20.9bnn.a.n.a.
Q2 202027$23.4bnn.a.n.a.
Q3 202031$21.9bnn.a.n.a.
Q4 202030$18.4bnn.a.n.a.
Q1 202131$15.4bnn.a.n.a.
Q2 202130$12.7bnn.a.n.a.
Q3 202135$10.1bnn.a.n.a.
Q4 202128$12.4bnn.a.n.a.
Q1 202223$16.1bnn.a.n.a.
Q2 202225$18.1bnn.a.n.a.
Q3 202222$18.4bnn.a.n.a.
Q4 202228$18.4bnn.a.n.a.
Q1 202326$21.4bnn.a.n.a.
Q2 202327$24.7bnn.a.n.a.
Q3 202333$24.3bnn.a.n.a.
Q4 202332$28.6bn1616
Q1 202431$29.8bn1619
Q2 202429$33.4bn1218
Q3 202427$33.5bn1710
Q4 202426$28.5bn1413
Q1 202521$35.4bn1011
Q2 202521$32.3bn1111
Q3 202522$25.9bn1310
Q4 202526$31.8bn1920
Q1 202625$31.8bn1721
Q2 202626$34.6bn2117
Q3 20263$195m12

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

VRTX and LLY →VRTX and JNJ →VRTX and GILD →Choose a stock to compare with VRTX →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own VRTX, latest filings →Back to the 13F Explorer →